INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS

被引:1324
作者
DANDREA, A [1 ]
ASTEAMEZAGA, M [1 ]
VALIANTE, NM [1 ]
MA, XJ [1 ]
KUBIN, M [1 ]
TRINCHIERI, G [1 ]
机构
[1] WISTAR INST ANAT & BIOL,3601 SPRUCE ST,PHILADELPHIA,PA 19104
关键词
D O I
10.1084/jem.178.3.1041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer cell stimulatory factor or interleukin 12 (NKSF/IL-12) is a heterodimeric cytokine produced by monocytes/macrophages, B cells, and possibly other accessory cell types primarily in response to bacteria or bacterial products. NKSF/IL-12 mediates pleiomorphic biological activity on T and NK cells and, alone or in synergy with other inducers, is a powerful stimulator of. interferon gamma (IFN-gamma) production. IL-10 is a potent inhibitor of monocyte-macrophage activation, that inhibits production of tumor necrosis factor alpha (TNF-alpha), IL-1 and also IFN-gamma from lymphocytes acting at the level of accessory cells. Because TNF-alpha and IL-1 are not efficient inducers of IFN-gamma, the mechanism by which IL-10 inhibits IFN-gamma production is not clear. In this paper, we show that IL-10 is a potent inhibitor of NKSF/IL-12 production from human peripheral blood mononuclear cells activated with Staphylococcus aureus or lipopolysaccharide (LPS). Both the production of the free NKSF/IL-12 p40 chain and the biologically active p70 heterodimer are blocked by IL-10. NKSF/IL-12 p40 chain mRNA accumulation is strongly induced by S. aureus or LPS and downregulated by IL-10, whereas the p35 mRNA is constitutively expressed and only minimally regulated by S. aureus, LPS, or IL-10. Although IL-10 is able to block the production of NKSF/IL-t2, a powerful inducer of IFN-gamma both in vitro and in vivo, the mechanism of inhibition of IFN-gamma by IL-10 cannot be explained only on the basis of inhibition of NKSF/IL-12 because IL-10 can partially inhibit IFN-gamma production induced by NKSF/IL-12, and also, the IFN-gamma production in response to various stimuli in the presence of neutralizing antibodies to NKSF/IL-12. Our findings that antibodies against NKSF/IL-12, TNF-alpha, or IL-1beta can significantly inhibit IFN-gamma production in response to various stimuli and that NKSF/IL-12 and IL-1beta can overcome the IL-10-mediated inhibition of IFN-gamma, suggest that IL-10 inhibition of IFN-gamma production is primarily due to its blocking production from accessory cells of the IFN-gamma-inducer NKSF/IL-12, as well as the costimulating molecule IL-1beta.
引用
收藏
页码:1041 / 1048
页数:8
相关论文
共 34 条
[21]   DIFFERENTIAL-EFFECTS OF IL-4-INDUCED AND IL-10-INDUCED ON IL-2-INDUCED IFN-GAMMA SYNTHESIS AND LYMPHOKINE-ACTIVATED KILLER ACTIVITY [J].
HSU, DH ;
MOORE, KW ;
SPITS, H .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (05) :563-569
[22]   IDENTIFICATION AND PURIFICATION OF NATURAL-KILLER CELL STIMULATORY FACTOR (NKSF), A CYTOKINE WITH MULTIPLE BIOLOGIC EFFECTS ON HUMAN-LYMPHOCYTES [J].
KOBAYASHI, M ;
FITZ, L ;
RYAN, M ;
HEWICK, RM ;
CLARK, SC ;
CHAN, S ;
LOUDON, R ;
SHERMAN, F ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :827-845
[23]  
MALEFYT RD, 1991, J EXP MED, V174, P1209
[24]   NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12 [IL-12]) INDUCES T-HELPER TYPE-1 (TH1)-SPECIFIC IMMUNE-RESPONSES AND INHIBITS THE DEVELOPMENT OF IL-4-PRODUCING TH CELLS [J].
MANETTI, R ;
PARRONCHI, P ;
GIUDIZI, MG ;
PICCINNI, MP ;
MAGGI, E ;
TRINCHIERI, G ;
ROMAGNANI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1199-1204
[25]   Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI [J].
Moore, Kevin W. ;
Vieira, Paulo ;
Fiorentino, David F. ;
Trounstine, Mary L. ;
Khan, Tariq A. ;
Mosmann, Timothy R. .
JOURNAL OF IMMUNOLOGY, 2012, 189 (05) :1230-1234
[26]   GAMMA-INTERFERON AND LYMPHOTOXIN, RELEASED BY ACTIVATED T-CELLS, SYNERGIZE TO INHIBIT GRANULOCYTE MONOCYTE COLONY FORMATION [J].
MURPHY, M ;
LOUDON, R ;
KOBAYASHI, M ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :263-279
[27]  
OSWALD IP, 1992, J IMMUNOL, V148, P3578
[28]  
PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171
[29]  
PERUSSIA B, 1992, J IMMUNOL, V149, P3495
[30]  
RALPH P, 1992, J IMMUNOL, V148, P808